Literature DB >> 1551900

Characterization of functional HPV-16 E7 protein produced in Escherichia coli.

D R Patrick1, K Zhang, D Defeo-Jones, G R Vuocolo, R Z Maigetter, M K Sardana, A Oliff, D C Heimbrook.   

Abstract

Human papillomaviruses (HPVs) are the etiologic agents responsible for genital warts and are contributing factors in the pathogenesis of human cervical cancer. The HPV E7 gene is transcriptionally active in these diseases and has been shown to transform mammalian cells in vitro. We have expressed and purified the HPV-16 E7 gene product in Escherichia coli. The isolated E7 protein contains zinc in a 1:1 molar ratio. X-ray absorption fine structure studies demonstrated that the zinc is coordinated by 4 sulfur ligands. We sequentially derivatized the E7 cysteines to differentiate between solvent-exposed, metal-bound, and disulfide-associated cysteines. Our results demonstrate that Cys24 and Cys68 are accessible to solvent, while cysteines in the two conserved Cys-X-X-Cys motifs are likely involved in binding zinc. We observed no evidence for the existence of disulfide bonds in recombinant E7 protein under the conditions tested.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551900

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7.

Authors:  C G Ullman; P I Haris; D A Galloway; V C Emery; S J Perkins
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

2.  The leader peptide of Theiler's murine encephalomyelitis virus is a zinc-binding protein.

Authors:  H H Chen; W P Kong; R P Roos
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

3.  Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16.

Authors:  G J Fernando; B Murray; J Zhou; I H Frazer
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

4.  Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding.

Authors:  M C McIntyre; M G Frattini; S R Grossman; L A Laimins
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts.

Authors:  D Defeo-Jones; G A Vuocolo; K M Haskell; M G Hanobik; D M Kiefer; E M McAvoy; M Ivey-Hoyle; J L Brandsma; A Oliff; R E Jones
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

6.  Recombinant HPV16 E7 assembled into particles induces an immune response and specific tumour protection administered without adjuvant in an animal model.

Authors:  Linda Petrone; Maria G Ammendolia; Armando Cesolini; Stefano Caimi; Fabiana Superti; Colomba Giorgi; Paola Di Bonito
Journal:  J Transl Med       Date:  2011-05-18       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.